Ok. So help me with this then.....
Seems I need a "little lesson".
Here is the clinical trial outline linked to from the NTI Clinical Trial Update 8th January:
https://clinicaltrials.gov/ct2/show/study/NCT02773303?term=Mente&rank=2
It says the trial's aims are:
This project aims:
- to further explore the effectiveness of a novel sonified Neurofeedback management therapy for children diagnosed with Autism Spectrum Disorder (ASD)
- to determine if balance control is different before and after therapy
And then the report presented at Cambridge Uni and summarised by NTI:
http://www.aspecthuntley.com.au/doc...Jyb3JwYWdlcy9wZGZkZWxheWVkLmpzcA==&popup=true
Says there were positive changes in neurological function.
BUT ... what neurological function?
The study was about
balance control - not about Austism. (Not surprising because Dr Carrick is ...
"known for establishing the chiropractic neurology subspecialty" and chiropractors would tend to be interested in balance.)
So I'm a bit puzzled. It seems the clinical study looks to have demonstrated improved
balance control but nothing about Autism (or APD).
Help me out here please.
